Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

W J McKenna, J T Stewart, P Nihoyannopoulos, F McGinty, M J Davies

Department of Cardiological Sciences, St George's Hospital Medical School, London.

Two families are described in which individuals showed widespread myocardial disarray at histological examination, in the absence of macroscopic cardiac hypertrophy. In one family the clinical presentation was that of sudden unexpected cardiac death in four family members; members of the other family presented with electrocardiographic repolarisation changes and abnormalities of left ventricular diastolic function. The finding of myocardial disarray, the characteristic histological abnormality of hypertrophic cardiomyopathy, in the absence of increased cardiac mass suggests a wider range of abnormality in hypertrophic cardiomyopathy than is currently recognised.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Hypertrophic cardiomyopathy: one disease or several?

M J Davies
Heart 1990 63: 263-264. [PDF]

This article has been cited by other articles:

• Ostman-Smith, I., Wisten, A., Nylander, E., Bratt, E.-L., de-Wahl Granelli, A., Oulhaj, A., Ljungstrom, E. (2009). Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy. Eur Heart J 0: ehp443v1-ehp443 [Abstract] [Full Text]  
• Efthimiadis, G. K., Meditskou, S., Parcharidis, G. E., Galvin, J. M., Arnold, J. R., Karamitsos, T. D., Petersen, S. E., Pelliccia, A., Maron, B. J. (2008). Athletes with Repolarization Abnormalities. NEJM 358: 2296-2298 [Full Text]  
• Kirschner, S. E., Becker, E., Antognozzi, M., Kubis, H.-P., Francino, A., Navarro-Lopez, F., Bit-Avragim, N., Perrot, A., Mirrakhimov, M. M., Osterziel, K.-J., McKenna, W. J., Brenner, B., Kraft, T. (2005). Hypertrophic cardiomyopathy-related {beta}-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. Am. J. Physiol. Heart Circ. Physiol. 288: H1242-H1251 [Abstract] [Full Text]  
• Maron, B. J., Seidman, J.G., Seidman, C. E. (2004). Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2125-2132 [Abstract] [Full Text]  
• Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., Camici, P. G. (2003). Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy. NEJM 349: 1027-1035 [Abstract] [Full Text]  
• Firoozi, S, Sharma, S, McKenna, W J (2003). Risk of competitive sport in young athletes with heart disease. Heart 89: 710-714 [Abstract] [Full Text]  
• Firoozi, S, Behr, E, McKenna, W (2003). Elite athletes with recurrent ERS. Eur Heart J 24: 783-783 [Full Text]  
• Jouven, X, Hagege, A, Charron, P, Carrier, L, Dubourg, O, Langlard, J M, Aliaga, S, Bouhour, J B, Schwartz, K, Desnos, M, Komajda, M (2002). Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 88: 153-157 [Abstract] [Full Text]  
• McKenna, W.J., Sharma, S., Elliott, P.M. (2001). Management strategies in hypertrophic cardiomyopathy: influence of age and morphology. Eur Heart J Suppl 3: L10-L14 [Abstract]  
• Janse, M.J., De Bakker, J.M.T. (2001). Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators. Eur Heart J Suppl 3: L15-L20 [Abstract]  
• Maron, B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., Seidman, C. E. (2001). Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 38: 315-321 [Abstract] [Full Text]  
• Sharma, S., Elliott, P. M., Whyte, G., Mahon, N., Virdee, M. S., Mist, B., McKenna, W. J. (2000). Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 36: 864-870 [Abstract] [Full Text]  
• Varnava, A, Baboonian, C, Davison, F, de Cruz, L, Elliott, P M, Davies, M J, McKenna, W J (1999). A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 82: 621-624 [Abstract] [Full Text]  
• Muthuchamy, M., Pieples, K., Rethinasamy, P., Hoit, B., Grupp, I. L., Boivin, G. P., Wolska, B., Evans, C., Solaro, R. J., Wieczorek, D. F. (1999). Mouse Model of a Familial Hypertrophic Cardiomyopathy Mutation in {alpha}-Tropomyosin Manifests Cardiac Dysfunction. Circ. Res. 85: 47-56 [Abstract] [Full Text]  
• Jung, W.-I., Sieverding, L., Breuer, J., Hoess, T., Widmaier, S., Schmidt, O., Bunse, M., van Erckelens, F., Apitz, J., Lutz, O., Dietze, G. J. (1998). 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy. Circulation 97: 2536-2542 [Abstract] [Full Text]  
• PRASAD, K, FRENNEAUX, M P (1998). Sudden death in hypertrophic cardiomyopathy: potential importance of altered autonomic control of vasculature. Heart 79: 538-540 [Full Text]  
• CHAMBERS, J, CARY, N, LARGE, S (1998). Histological findings in non-hypertrophic cardiomyopathy associated with Noonan's syndrome. Heart 79: 206a-206 [Full Text]  
• Charron, P., Dubourg, O., Desnos, M., Isnard, R., Hagege, A., Millaire, A., Carrier, L., Bonne, G., Tesson, F., Richard, P., Bouhour, J.-B., Schwartz, K., Komajda, M. (1997). Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population. Circulation 96: 214-219 [Abstract] [Full Text]  
• Maron, B. J., Shirani, J., Poliac, L. C., Mathenge, R., Roberts, W. C., Mueller, F. O. (1996). Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles. JAMA 276: 199-204 [Abstract]  
• Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J. III, Gersh, B. J. (1995). Natural History of Hypertrophic Cardiomyopathy : A Population-Based Study, 1976 Through 1990. Circulation 92: 2488-2495 [Abstract] [Full Text]  
• Wigle, E. D., Rakowski, H., Kimball, B. P., Williams, W. G. (1995). Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment. Circulation 92: 1680-1692 [Full Text]  
• Fananapazir, L., Epstein, N. D. (1995). Prevalence of Hypertrophic Cardiomyopathy and Limitations of Screening Methods. Circulation 92: 700-704 [Full Text]  
• Schwartz, K., Carrier, L., Guicheney, P., Komajda, M. (1995). Molecular Basis of Familial Cardiomyopathies. Circulation 91: 532-540 [Full Text]  
• Witt, C. C., Gerull, B., Davies, M. J., Centner, T., Linke, W. A., Thierfelder, L. (2001). Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C. J. Biol. Chem. 276: 5353-5359 [Abstract] [Full Text]